AmDen Pharmaceuticals Denmark ApS — Credit Rating and Financial Key Figures
CVR number: 42045403
Vandværksvej 5, Valløby 4600 Køge
flemmingdyremose@amphade.com
tel: 60155843
Income statement (kDKK)
2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|
Fiscal period length | 12 | 12 | 12 | 12 |
Net sales | ||||
Gross profit | 750.00 | -7.00 | -5.00 | -7.81 |
EBIT | 750.00 | -7.00 | -5.00 | -7.81 |
Other financial expenses | -1.00 | -10.00 | -2.00 | -0.79 |
Pre-tax profit | 749.00 | -17.00 | -7.00 | -8.60 |
Income taxes | - 165.00 | 2.00 | 2.00 | 1.00 |
Net earnings | 584.00 | -15.00 | -5.00 | -7.60 |
Assets (kDKK)
2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|
Intangible assets total | ||||
Tangible assets total | ||||
Investments total | ||||
Long term receivables total | ||||
Inventories total | ||||
Current other receivables | 1.00 | 0.57 | ||
Current deferred tax assets | 2.00 | 4.00 | 25.00 | |
Short term receivables total | 2.00 | 5.00 | 25.57 | |
Cash and bank deposits | 795.00 | 40.00 | 32.00 | 10.45 |
Cash and cash equivalents | 795.00 | 40.00 | 32.00 | 10.45 |
Balance sheet total (assets) | 795.00 | 42.00 | 37.00 | 36.02 |
Equity and liabilities (kDKK)
2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|
Share capital | 40.00 | 40.00 | 40.00 | 40.00 |
Shares repurchased | 574.00 | |||
Retained earnings | - 574.00 | 10.00 | -5.00 | -9.50 |
Profit of the financial year | 584.00 | -15.00 | -5.00 | -7.60 |
Shareholders equity total | 624.00 | 35.00 | 30.00 | 22.90 |
Non-current liabilities total | ||||
Current trade creditors | 7.00 | 7.00 | 7.00 | 6.50 |
Current owed to participating | 6.25 | |||
Short-term deferred tax liabilities | 163.00 | |||
Other non-interest bearing current liabilities | 1.00 | 0.37 | ||
Current liabilities total | 171.00 | 7.00 | 7.00 | 13.12 |
Balance sheet total (liabilities) | 795.00 | 42.00 | 37.00 | 36.02 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions

... and more!
No registration needed.